Chapter 2 Drug Design Strategies 41 R E V I E W Q U E S T I O N S 1. Name at least two ways that a drug’s pharmacological half-life may be shortened following administration. 2. Define conjugate acid and conjugate base. 3. Estimate the percent ionization of acetic acid (pKa 4.8) at pH 3.8 and at pH 5.8. 4. Would you expect selegiline to be more water soluble or insoluble at physiological pH. (Look up selegiline’s pKa in the Appendix.) 5. What does each of the following acronyms represent? QSAR, CADD, CoMFA, CoMSIA, Log P, Log D, HTS 6. Rank order the following bond types from weakest to strongest: van der Waals, covalent, hydrogen, ionic, dipole–dipole. 7. What is Lipinski Rule of Five? Give one application where it can be applied. REFERENCES 1. Crum Brown, A., and Fraser, T.: R. Soc. Edinburgh 25:151, 1868–1869. 2. Grime, J. M. A., Edwards, M. A., Rudd, N. C., et al.: Proc. Nat. Acad. Sci. 105:14277, 2008. 3. Benfenati, E., Gini, G., Piclin, N., et al.: Chemosphere 53:1155, 2003. 4. Mannhold, R., Poda, G. I., Ostermann, C. E., et al.: J. Pharm. Sci. 98:861, 2009. 5. Hansch, C., Leo, A., and Hoekman, D.: Exploring QSAR: Hydrophobic, Electronic, and Steric Constants. Washington, DC, American Chemical Society, 1995. 6. Hansch, C., and Lien, E. J.: J. Med. Chem. 14:653, 1971. 7. Dearden, J. C., and George, E.: J. Pharm. Pharmacol. 31:S45P, 1979. 8. Stuper, A. J., Brügger, W. E., and Jurs, P. C.: Computer Assisted Studies of Chemical Structure and Biological Function. New York, John Wiley & Sons, 1979. 9. Martin, Y. C., Kofron, J. L., and Traphagen, L. M.: J. Med. Chem. 45:4350, 2002. 10. Maggiora, G. M.: J. Chem. Inf. Model. 46:1535, 2006. 11. Doweyko, A. M.: J. Computer-Aided Molec. Design 22:81, 2008. 12. Eriksson, L. E., Jaworska, J., Worth, A. P., et al.: Environmental Health Perspectives 111:1361, 2003. 13. Konovalov, D. A., Llewellyn, L. E., Heyden, Y. V., et al.: J. Chem. Inf. Model. 48:2081, 2008. 14. Roy, P. P., Paul, S., Mitra, I., et al.: Molecules 14:1660, 2009. 15. Gedeck, P., Rohde, B., and Bartels, C.: J. Chem. Inf. Model. 46:1924, 2006. 16. Johnson, S. R.: J. Chem. Inf. Model. 48:25, 2008. 17. Baker, B. R.: J. Pharm. Sci. 53:347, 1964. 18. Chiou, C. Y., Long, J. P., Cannon, J. G., et al.: J. Pharmacol. Exp. Ther. 166:243, 1969. 19. Smissman, E., Nelson, W., Day, J., et al.: J. Med. Chem. 9:458, 1966. 20. Burkert, U., and Allinger, N. L.: Molecular Mechanics. ACS Monograph 177. Washington, DC, American Chemical Society, 1982. 21. Rappe, A. K., and Casewit, C.: Molecular Mechanics Across Chemistry. Sausalito, CA, University Science Books, 1992. 22. Greer, J., Erickson, J. W., Baldwin, J. J., et al.: J. Med. Chem. 37:1035, 1994. 23. Carson, M., and Bugg, C. E.: J. Mol. Graphics 4:121, 1986. 24. Richardson, J. S., and Richardson, D. C.: Trends Biochem. Sci. 14:304, 1989. 25. Connolly, M. L.: Science 221:709, 1983. 26. Lee, B., and Richards, F. M.: J. Mol. Biol. 55:379, 1971. 27. Warren, G. L., Andrews, C. W., Capelli, A., et al.: J. Med. Chem. 49:5912, 2006. 28. Leach, A. R., Shoichet, B. K., and Peishoff, C. E.: J. Med. Chem.: 49: 5851, 2006. 29. Huang, H., Shoichet, B. K., and Irwin, J. J.: J. Med. Chem.: 49:6789, 2006. 30. Hopfinger, A. J., and Burke, B. J.: Molecular shape analysis: a formalism to quantitatively establish spatial molecular similarity. In Johnson, M. A., and Maggiora, G. M. (eds.). Concepts and Applications of Molecular Similarity. New York, John Wiley & Sons, 1990. 31. Srivastava, S., Richardson, W. W., Bradely, M. P., et al.: Three di- mensional receptor modeling using distance geometry and Voronoi polyhydra. In Kubinyi, H. (ed.). 3D QSAR in Drug Design: Theory, Methods and Applications. Leiden, The Netherlands, ESCOM, 1993. 32. Good, A. C., Peterson, S. J., and Richards, W. G.: J. Med. Chem. 36:2929, 1993. 33. Good, A. C., and Richards, W. G.: Drug Inf. J. 30:371, 1996. 34. Kier, L. B., and Hall, L. H.: Molecular Connectivity in Chemistry and Drug Research. New York, Academic Press, 1976. 35. Kier, L. B., and Hall, L. H.: Molecular Connectivity in Structure Activity Analysis. New York, Research Studies Press (Wiley), 1986. 36. Bonchev, D.: Information Theoretic Indices for Characterization of Chemical Structures. New York, Research Studies Press (Wiley), 1983. 37. Cramer III, R. D., Patterson, D. E., and Bunce, J. D.: J. Am. Chem. Soc. 110:5959, 1988. 38. Marshall, G. R., and Cramer III, R. D.: Trends Pharmacol. Sci. 9:285, 1988. 39. Krasowski, M. D., Hong, X., Hopfinger, A. J., et al.: J. Med. Chem. 45:3210, 2002. 40. Kleve, G.: 3D QSAR in Drug Design. In Kubinyi, H., Folkers, G., and Martin, Y. C. (eds.). Three-Dimensional Quantitative Structure- Activity Relationships, vol. 3. New York, Springer, 1998. 41. Lipinski, C. A.: J. Pharmacol. Toxicol. Methods 44:235, 2000. 42. Lipinski, C. A., Lombardo, F., Dominy, B. W., et al.: Adv. Drug Deliv. Rev. 46:3, 2001. 43. Bhal, S. K., Kassam, K., Peirson, I. G., et al.: Mol. Pharm. 4:556, 2007. 44. Kah, M., and Brown, C. D.: Chemosphere 72:1401, 2008. 45. Ghose, A. K., Viswanadhan, V. N., and Wendoloski, J. J.: J. Comb. Chem. 1:55, 1999. 46. Congreve, M., Chessari, G., Tisi, D., et al.: J. Med. Chem. 51:3661, 2008. 47. Langmuir, I.: J. Am. Chem. Soc. 41:1543, 1919. 48. Patani, G. A., and LaVoie, E. J.: Chem Rev. 96:3147, 1996. 49. Kubinyi, H.: Success Stories of Computer-Aided Design. In Ekins, S. (ed.). Computer Applications in Pharmaceutical Research and Development. New York, Wiley-Interscience, 2006, p. 377. 50. Boyd, D. B.: In Lipkowitz, K. B. and Cundari, T. R., (eds.). Reviews in Computational Chemistry. 23:401, 2007. SELECTED READING Abraham, D. (ed.): Burger’s Medicinal Chemistry and Drug Discovery, 6th ed. New York, Wiley-Interscience, 2003. Albert, A.: Selective Toxicity, 7th ed. New York, Chapman & Hall, 1985. Cramer, C. J.: Essentials of Computational Chemistry: Theories and Models. New York, Wiley, 2002. Dean, P. M. (ed.): Molecular Similarity in Drug Design. New York, Chapman & Hall, 1995. Devillers, J., and Balaban, A. T., (eds.): Topological Indices and Related Descriptors in QSAR and QSPR. Amsterdam, Gordon and Breach, 1999. Franke, R.: Theoretical drug design methods. In Nauta, W. T., and Rekker, R. F. (eds.). Pharmacochemistry Library, vol. 7. New York, Elsevier, 1984.